Tex. Occ. Code § 562.156 · Subchapter D. COMPOUNDED AND PREPACKAGED DRUGS
COMPOUNDED STERILE PREPARATION; NOTICE TO BOARD.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) A pharmacy may not compound and dispense a sterile preparation unless the pharmacy holds a license as required by board rule.
(b) A pharmacy that compounds a sterile preparation shall notify the board:
(1) immediately of any adverse effects reported to the pharmacy or that are known by the pharmacy to be potentially attributable to a sterile preparation compounded by the pharmacy; and
(2) not later than 24 hours after the pharmacy issues a recall for a sterile preparation compounded by the pharmacy.
Notes and commentary — not statutory text
History
Added by Acts 2013, 83rd Leg., R.S., Ch. 608 (S.B. 1100), Sec. 6, eff. September 1, 2013.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/OC/htm/OC.562.htm
- Text hash
- sha256 f7e2af758b7f0aace6844e67ba33fc250ee9d0344f32432ada3501ee898e3f63
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.